Menu

Blog

Archive for the ‘health’ category: Page 241

May 7, 2020

The Harvard Wyss Institute’s response to COVID-19: beating back the coronavirus

Posted by in categories: biotech/medical, genetics, health

Diagnosing COVID-19 more quickly, easily, and broadly

With COVID-19 rapidly spreading around the planet, the efficient detection of the CoV2 virus is pivotal to isolate infected individuals as early as possible, support them in whatever way possible, and thus prevent the further uncontrolled spread of the disease. Currently, the most-performed tests are detecting snippets of the virus’ genetic material, its RNA, by amplifying them with a technique known as “polymerase chain reaction” (PCR) from nasopharyngeal swabs taken from individuals’ noses and throats.

The tests, however, have severe limitations that stand in the way of effectively deciding whether people in the wider communities are infected or not. Although PCR-based tests can detect the virus’s RNA early on in the disease, test kits are only available for a fraction of people that need to be tested, and they require trained health care workers, specialized laboratory equipment, and significant time to be performed. In addition, health care workers that are carrying out testing are especially prone to being infected by CoV2. To shorten patient-specific and community-wide response times, Wyss Institute researchers are taking different parallel approaches:

May 7, 2020

Health & Aging post COVID-19: Ole | Apollo, Aubrey | SENS, Sonia | 100 Plus Capital, Reason | Repair

Posted by in categories: biotech/medical, health

Aubrey De Grey and Reason from ’ Fight Aging’:


How can the current public focus on health be leveraged to promote a focus on prevention of disease, and aging as root cause for diseases?

Continue reading “Health & Aging post COVID-19: Ole | Apollo, Aubrey | SENS, Sonia | 100 Plus Capital, Reason | Repair” »

May 5, 2020

How Bill Gates Monopolized Global Health

Posted by in categories: biotech/medical, business, health

https://www.youtube.com/watch?v=wQSYdAX_9JY&feature=share

TRANSCRIPT AND MP3: www.corbettreport.com/gates

Who is Bill Gates? A software developer? A businessman? A philanthropist? A global health expert? This question, once merely academic, is becoming a very real question for those who are beginning to realize that Gates’ unimaginable wealth has been used to gain control over every corner of the fields of public health, medical research and vaccine development. And now that we are presented with the very problem that Gates has been talking about for years, we will soon find that this software developer with no medical training is going to leverage that wealth into control over the fates of billions of people.

May 5, 2020

Could Deep Breathing Exercises Protect You From the Worst Symptoms of COVID-19?

Posted by in categories: biotech/medical, health

Deep Breathing alone will not create new lung cells, but combined with deep relaxation, guided visualizations, and therapeutic messages (Your stem cells are going to transform themselves into new lung cells to replace those lung cells infected by the Coronavirus. Your stem cells are going to change themselves into T-Cells, B-Cells, and Natural Killer Cells which are going to seek out, identify, attack, and destroy all the Coronavirus cells in your entire body), it will eliminate the coughing, fever, headaches, inflammation, and breathing problems.

While there is no hard evidence that lung exercises can help ease the discomfort and the progression of symptoms of COVID-19, there are techniques that will restore your lungs to optimal health.

May 5, 2020

Paradoxes of Probability & Statistical Strangeness

Posted by in categories: food, health

Statistics is a useful tool for understanding the patterns in the world around us. But our intuition often lets us down when it comes to interpreting those patterns. In this series we look at some of the common mistakes we make and how to avoid them when thinking about statistics, probability and risk.

You don’t have to wait long to see a headline proclaiming that some food or behavior is associated with either an increased or a decreased health risk, or often both. How can it be that seemingly rigorous scientific studies can produce opposite conclusions?

Nowadays, researchers can access a wealth of software packages that can readily analyze data and output the results of complex statistical tests. While these are powerful resources, they also open the door to people without a full statistical understanding to misunderstand some of the subtleties within a dataset and to draw wildly incorrect conclusions.

May 4, 2020

France’s first Covid-19 case ‘dates back to December’, flu retest shows

Posted by in categories: biotech/medical, health, security

Murphy’s Law: Everything that can go wrong will in fact go wrong.

Here is how to set the table for Murphy’s Law and become the epic center in the world for the COVID-19:

A. Eliminate the entire global health security team at the White House. Their job? Managing pandemics like COVID-19.

Continue reading “France’s first Covid-19 case ‘dates back to December’, flu retest shows” »

May 4, 2020

New guidelines for treating the sickest COVID-19 patients

Posted by in categories: biotech/medical, health

A new set of recommendations for health care workers on the front lines, to help them make decisions on how to treat the most critical COVID-19 patients, those with severe lung or heart failure, has been published.

May 4, 2020

‘Unnecessary’ genetic complexity: A spanner in the works?

Posted by in categories: biotech/medical, genetics, health

The breakthrough, which identified the location and function of every human gene, offered the promise of medical care tailored specifically to individual patients, based on their personal genetic makeup.

When researchers identified a gene associated with a 44 per cent risk of breast cancer in women, for example, it seemed that protecting them might be as simple as deactivating that gene.

But the promise of such personalized medicine has not fully materialized, say two McMaster researchers, because the full sophistication of the genetic blueprint has a more complex and far-reaching influence on human health than scientists had first realized.

May 4, 2020

Antibody prevents the COVID-19 virus from infecting human cells

Posted by in categories: biotech/medical, genetics, health

Antibody found to block infection by the novel coronavirus SARS-CoV-2 in cells.

The ‘47D11’ antibody targets the ‘spike protein’ of the destructive coronavirus.

Continue reading “Antibody prevents the COVID-19 virus from infecting human cells” »

May 4, 2020

Ban on gain-of-function studies ends

Posted by in categories: biotech/medical, government, health, policy, surveillance

The debate is focused on a subset of gain-of-function studies that manipulate deadly viruses to increase their transmissibility or virulence. “This is what happens to viruses in the wild”, explains Carrie Wolinetz, head of the NIH Office of Science Policy. “Gain-of-function experiments allow us to understand how pandemic viruses evolve, so that we can make predictions, develop countermeasures, and do disease surveillance”. Although none of the widely publicised mishaps of 2014 involved such work, the NIH decided to suspend funding for gain-of-function studies involving influenza, MERS-CoV, and SARS-CoV.


The US moratorium on gain-of-function experiments has been rescinded, but scientists are split over the benefits—and risks—of such studies. Talha Burki reports.

On Dec 19, 2017, the US National Institutes of Health (NIH) announced that they would resume funding gain-of-function experiments involving influenza, Middle East respiratory syndrome coronavirus, and severe acute respiratory syndrome coronavirus. A moratorium had been in place since October, 2014. At the time, the NIH had stated that the moratorium “will be effective until a robust and broad deliberative process is completed that results in the adoption of a new US Government gain-of-function research policy”. This process has now concluded. It was spearheaded by the National Science Advisory Board for Biosecurity (NSABB) and led to the development of a new framework for assessing funding decisions for research involving pathogens with enhanced pandemic potential. The release of the framework by the Department of Health and Human Services (HHS), of which NIH is part, signalled the end of the funding pause.

Continue reading “Ban on gain-of-function studies ends” »